期刊文献+

Bile acids as drivers and biomarkers of hepatocellular carcinoma 被引量:2

下载PDF
导出
摘要 The prevalence of hepatocellular carcinoma(HCC)is rapidly increasing,driven not least in part by the escalating prevalence of non-alcoholic fatty liver disease.Bile acid(BA)profiles are altered in patients with HCC and there is a developing body of evidence from in vitro human cellular models as well as rodent data suggesting that BA are able to modulate fundamental processes that impact on cellular phenotype predisposing to the development of HCC including senescence,proliferation and epithelial-mesenchymal transition.Changes in BA profiles associated with HCC have the potential to be exploited clinically.Whilst excellent diagnostic and imaging tools are available,their use to screen populations with advanced liver disease at risk of HCC is limited by high cost and low availability.The mainstay for HCC screening among subjects with cirrhosis remains frequent interval ultrasound scanning.Importantly,currently available serum biomarkers add little to diagnostic accuracy.Here,we review the current literature on the use of BA measurements as predictors of HCC incidence in addition to their use as a potential screening method for the early detection of HCC.Whilst these approaches do show early promise,there are limitations including the relatively small cohort sizes,the lack of a standardized approach to BA measurement,and the use of inappropriate control comparator samples.
出处 《World Journal of Hepatology》 2022年第9期1730-1738,共9页 世界肝病学杂志(英文版)(电子版)
  • 相关文献

参考文献1

二级参考文献14

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics [ J]. CA Cancer J Clin, 2011, 61:69-90.
  • 2Morales-Romero J, Vargas G, Garcia-Romtin R. Occult HBV infection: a faceless enemy in liver cancer development [ J ]. Viruses, 2014, 6 : 1590-1611.
  • 3Kang JH, Zhang WQ, Song W, et al. Apoptosis mechanism of human cholangiocarcinoma ceils induced by bile extract from crocodile [ J ]. Appl Biochem Biotechnol, 2012, 166:942-951.
  • 4Fimognari C, Lenzi M, Cantelli-Forti G, et al. Apoptosis and modulation of cell cycle control by bile acids in human leukemia T cells [J]. Ann N Y Acad Sci, 2009, 1171:264-269.
  • 5Shiraki K, Ito T, Sugimoto K, et al. Different effects of bile acids, ursodeoxycholic acid and deoxycholic acid, on cell growth and cell death in human colonic adenocarcinoma cells [ J]. Int J Mol Med, 2005, 16:729-733.
  • 6Khare S, Cerda S, Wali RK, et al. Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer [ J ]. Cancer Res, 2003, 63 : 3517- 3523.
  • 7Alberts DS, Martinez ME, Hess LM, et al. Phase III trial of ursodeoxyeholic acid to prevent colorectal adenoma recurrence [ J ]. Journal of the National Cancer Institute, 2005,97:846-853.
  • 8Nieolson GL. Metabolic syndrome and mitochondrial function: molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function [ J ]. Journal of cellular biochemistry, 2007, 100 : 1352-1369.
  • 9Adrain C, Creagh EM, Martin SJ. Defying death: showing Bcl-2 the way home [J]. Nat Cell Biol, 2003, 5:9-11.
  • 10Ola MS, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis [ J ]. Mol Cell Biochem , 2011, 351:41-58.

共引文献1

同被引文献12

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部